Drug Approval | March 23, 2022
Covovax for teens get DCGI nod
It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D
It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D
The facility will produce 150 million vaccine doses per year
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
_256_384.jpg){kind=logo}
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
This is the ninth Covid-19 vaccine approved in India
Pfizer and Moderna are also working on vaccines that target the Omicron variant
The vaccines are currently only authorised for emergency use in the country
However, these won’t be available at the nearest chemist store soon
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
Subscribe To Our Newsletter & Stay Updated
